首页|期刊导航|中国神经再生研究:英文版|Cannabinoids and endocannabinoids as therapeutics for nervous system disorders:preclinical models and clinical studies

Cannabinoids and endocannabinoids as therapeutics for nervous system disorders:preclinical models and clinical studies

R.Scott Duncan Sean M.Riordan Matthew C.Gernon Peter Koulen

中国神经再生研究:英文版2024，Vol.19Issue(4)：P.788-799,12.

中国神经再生研究:英文版2024，Vol.19Issue(4)：P.788-799,12.DOI:10.4103/1673-5374.382220

Cannabinoids and endocannabinoids as therapeutics for nervous system disorders:preclinical models and clinical studies

R.Scott Duncan ¹Sean M.Riordan ¹Matthew C.Gernon ¹Peter Koulen²

作者信息

1. Department of Ophthalmology,School of Medicine,University of Missouri
2. Department of Ophthalmology,School of Medicine,University of Missouri Department of Biomedical Sciences,School of Medicine,University of Missouri
折叠

摘要

关键词

anandamide/cannabidiol/cannabinoid/endocannabinoid/epilepsy/multiple sclerosis/neurodegeneration/neuroprotection/tetrahydrocannabinol

分类

医药卫生

引用本文复制引用

R.Scott Duncan,Sean M.Riordan,Matthew C.Gernon,Peter Koulen..Cannabinoids and endocannabinoids as therapeutics for nervous system disorders:preclinical models and clinical studies[J].中国神经再生研究:英文版,2024,19(4):P.788-799,12.

基金项目

supported in part by grants from the National Institute on Aging and National Eye Institute[EY030747(3R01EY030747-02S2)and EY031248(3R01EY03124802S1)]of the National Institutes of Health(to PK) （3R01EY030747-02S2）

Additional support by the Felix and Carmen Sabates Missouri Endowed Chair in Vision Research （）

the Vision Research Foundation of Kansas City。（）

中国神经再生研究:英文版

OACSTPCD

ISSN：1673-5374

访问量0

下载量0

段落导航